As of 2025-07-07, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 12.5x | 11.8x |
| Forward P/E multiples | 11.7x - 20.1x | 17.0x |
| Fair Price | (99.46) - (103.78) | (112.77) |
| Upside | -7467.4% - -7787.0% | -8453.6% |
| Date | EV/EBITDA |